Regulatory & compliance
Covid-19 coronavirus: patent database observations
14 September 2020 - Posted by: Lars Braams
As per 8 September 2020, 143 search results containing the words “Covid 19” in the title, claims or the abstract of a patent show up in the international patent database Espacenet. Over the past weeks, this number grows with about 15 new results each week. While the race for a vaccine covers the headlines around › Read More
French anti-gift regulation is now complete!
24 August 2020 - Posted by: Jeanne Fabre
The two long-awaited orders of the French anti-gift regulation were finally published on 14 August 2020 (see our previous blog post: Decree on French anti-gift regulation published): Order of 7 August 2020 setting the amounts from which an agreement provided for in Article L1453-8 of the Public Health Code and specifying the granting of benefits › Read More
05 August 2020 - Posted by: Jeanne Fabre
At the end of the Conventional Policy Steering Committee held on 23 July 2020, the French Pharmaceutical Companies Association (Leem) and the French Economic Committee for Health Products (CEPS) agreed to an extension of their Framework Agreement, which is the reference framework for fixing and regulating medicines pricing in France. The agreement, which would have › Read More
Belgium: Covid-19: use of unlicensed medicines for treatment of Covid-19
03 August 2020 - Posted by: Tine Carmeliet
Recently, Royal Decree no 34 was published, containing measures to ensure the availability and proper management of medicinal products during the Covid-19 pandemic. The royal decree enables the Minister of Health to authorise a product from Belgium’s strategic stockpile of medicinal products that is not licensed for the treatment of Covid-19 to be used for › Read More
15 July 2020 - Posted by: Eveline Van Keymeulen
Further to the previous publications by the French High Health Authority (HAS), the French Health Ministry published on 21 May 2020 the list of serological tests deemed reliable and validated by the National Reference Centre for respiratory infection viruses (CNR) on its Covid-19 platform (see our previous post here). On the same date, a new › Read More